News blog

NextGen Group

  • BY: Andrew Hore |
  • POSTED: 23/04/2008 |

NextGen plans to focus on its biomarker testing, discovery and assay development services.

This market is forecast to grow to $21bn over the next five years. NextGen will move its base to the US and start reporting in US dollars in the second half of 2008. 

The plan is to wind down or sell the UK-based software and instrumentation businesses and its protein production fee for service business. This should be completed over the next six months.

The 2007 results will be released in the week beginning 12 May.

The shares were unchanged at 0.225p.

© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds